| Size & multiples | |||
| Market Cap | $59.7M | Enterprise Value | $59.4M |
| P/E (TTM) | 14.18× | PEG (trailing) | — |
| P/S | 0.49× | P/FCF | 7.68× |
| EV/EBITDA | 7.44× | EV/EBIT | 18.00× |
| EV/Sales | 0.49× | EV/FCF | 7.64× |
| FCF Yield | 13.02% | Buyback Yield | — |
| Owner Earnings (TTM) | $5.1M | Owner Earnings Yield | 8.59% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | −0.16 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 3.20% |
| After-tax Cost of Debt | 22.07% | Synthetic credit rating | B- |
| Cost of Debt · embedded (pre-tax) | 31.07% | Cost of Debt · marginal (synthetic) | 9.09% |
| WACC | 6.32% | ROIC | 9.65% |
| EVA Spread (ROIC−WACC) | 3.34% | EVA | $1.6M |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted), Interest Expense · EPS TTM $0.03 · revenue TTM $121.9M · FCF TTM $7.8M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E, EV/EBITDA
P/E 29th · EV/EBITDA 6th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 14.2x | 24.4x | 13.0x–39.3x | 29 ↓cheap |
| EV/EBITDA | 4.6x | 15.1x | 9.8x–24.4x | 6 ↓cheap |
| FCF Yield | 17.0% | -7.8% | -34.7%–1.4% | 97 ↑strong |
| Net Margin | 3.7% | -21.2% | -325.3%–7.2% | 69 ↑strong |
| Operating Margin | 5.4% | -34.5% | -552.0%–8.0% | 71 ↑strong |
| ROE | 10.6% | -36.8% | -92.5%–4.5% | 81 ↑strong |
